Trial intelligence / Profile preview

Envarsus XR vs Prograf in Kidney Transplantation

NCT03511560Phase 4Completed

Sponsor
Columbia University
Start
Jul 2018
Primary completion
Jul 2020
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Columbia University. Started Jul 2018; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT03511560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03511560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call